Understanding how protein phosphorylation affects health and disease
Protein Phosphorylation in Health and Disease
['FUNDING_OTHER'] · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · NIH-10905914
This study is looking at how certain proteins help cells talk to each other and how problems with this communication can lead to diseases like diabetes, inflammation, and cancer, and it’s designed for researchers and new scientists who want to learn and share ideas to find better treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FEDERATION OF AMER SOC FOR EXPER BIOLOGY (nih funded) |
| Locations | 1 site (Rockville, UNITED STATES) |
| Trial ID | NIH-10905914 on ClinicalTrials.gov |
What this research studies
This research investigates the role of protein phosphorylation in cellular communication and its implications for diseases such as diabetes, inflammation, and cancer. It focuses on how kinases and phosphatases regulate this process and how their dysregulation can lead to disease. The project aims to enhance knowledge through the participation of trainees and junior faculty at a key conference dedicated to this topic, fostering collaboration and innovation in therapeutic development. By bringing together experts from various fields, the research seeks to advance our understanding of biochemical mechanisms related to phosphorylation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by diseases related to protein phosphorylation, such as cancer or diabetes.
Not a fit: Patients with conditions unrelated to protein phosphorylation or those not currently affected by cancer or diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapeutic strategies for diseases like cancer and diabetes by enhancing our understanding of protein phosphorylation.
How similar studies have performed: Previous research has shown success in targeting protein kinases for cancer treatment, indicating that this approach has potential for significant advancements.
Where this research is happening
Rockville, UNITED STATES
- FEDERATION OF AMER SOC FOR EXPER BIOLOGY — Rockville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAGLIABRACCI, VINCENT SCOTT — FEDERATION OF AMER SOC FOR EXPER BIOLOGY
- Study coordinator: TAGLIABRACCI, VINCENT SCOTT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents